WallStreetZenWallStreetZen

NASDAQ: PCRX
Pacira Biosciences Inc Stock Ownership - Who owns Pacira Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pacira Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shawn CrossChief Financial Officer2025-12-109,104$25.14
$228.87kSell
Shawn CrossChief Financial Officer2025-12-109,104$16.45
$149.76kBuy
Shawn CrossChief Financial Officer2025-12-0915,896$16.45
$261.49kBuy
Shawn CrossChief Financial Officer2025-12-0915,896$25.03
$397.88kSell
Jonathan SloninChief Medical Officer2025-11-173,960$24.09
$95.40kSell
Shawn CrossChief Financial Officer2025-11-1012,060$22.09
$266.41kSell
Shawn CrossChief Financial Officer2025-10-316,690$21.38
$143.03kSell
Abraham CeesayDirector2025-09-042,354$27.19
$64.01kSell
Marcelo BigalDirector2025-08-074,912$23.67
$116.27kSell
Jonathan SloninChief Medical Officer2025-08-01315$22.07
$6.95kSell

1 of 2

PCRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PCRX insiders and whales buy or sell their stock.

PCRX Shareholders

What type of owners hold Pacira Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc17.05%7,336,198$189.86MInstitution
Orbimed Advisors LLC12.26%5,274,941$136.52MInsider
Vanguard Group Inc12.08%5,197,567$134.51MInstitution
Andreas Wicki9.50%4,085,359$105.73MInsider
Carl L. Gordon6.58%2,828,941$73.21MInsider
Mpm Bioventures IV Qp LP6.49%2,790,479$72.22MInsider
Vaughn M. Kailian6.49%2,790,479$72.22MInsider
Doma Perpetual Capital Management LLC6.28%2,701,324$69.91MInstitution
Hbm Healthcare Investments Cayman Ltd5.19%2,233,993$57.82MInsider
Dimensional Fund Advisors LP5.03%2,163,473$55.99MInstitution

1 of 3

PCRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PCRX67.54%32.46%Net SellingNet Selling
EVO5.56%0.00%
TLRY85.62%14.38%Net Buying
CRON13.26%49.08%Net SellingNet Selling
AMPH48.29%51.71%Net BuyingNet Selling
View Top Pharmaceutical Stocks

Pacira Biosciences Stock Ownership FAQ

Who owns Pacira Biosciences?

Pacira Biosciences (NASDAQ: PCRX) is owned by 111.48% institutional shareholders, 53.57% Pacira Biosciences insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Pacira Biosciences shareholder, owning 5.27M shares representing 12.26% of the company. Orbimed Advisors LLC's Pacira Biosciences shares are currently valued at $136.52M.

If you're new to stock investing, here's how to buy Pacira Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.